Gardasil® 9 Human Papillomavirus Vaccine (HPV) Indicated for People 9 to 45 Years of Age 20 mcg - 60 mcg / 0.5 mL Injection Prefilled Syringe Intramuscular

Features

• GARDASIL 9 is a non-infectious recombinant 9-valent vaccine prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein of HPV Types 6
• 11
• 16
• 18
• 31
• 33
• 45
• 52
• and 58 Each 0.5-mL dose contains approximately 30 mcg of HPV Type 6 L1 protein
• 40 mcg of HPV Type 11 L1 protein
• 60 mcg of HPV Type 16 L1 protein
• 40 mcg of HPV Type 18 L1 protein
• 20 mcg of HPV Type 31 L1 protein
• 20 mcg of HPV Type 33 L1 protein
• 20 mcg of HPV Type 45 L1 protein
• 20 mcg of HPV Type 52 L1 protein
• and 20 mcg of HPV Type 58 L1 protein Administer GARDASIL 9 intramuscularly as a 0.5-mL dose at the following schedule: 0
• 2 months
• 6 months Not all vulvar
• vaginal
• and anal cancers are caused by HPV
• and GARDASIL 9 protects only against those vulvar
• vaginal
• and anal cancers caused by HPV 16
• 18
• 31
• 33
• 45
• 52 and 58